Noriaki Nakaya Selected Research

Hypercholesterolemia

6/2012	The effect of low-dose pravastatin in metabolic syndrome for primary prevention of cardiovascular disease in Japan: a post hoc analysis of the MEGA study.
3/2012	Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study.
1/2012	Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia.
1/2012	The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid.
9/2011	Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).
1/2011	Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old).
8/2010	Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese.
7/2010	Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease.
3/2010	Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.
10/2009	Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriaki Nakaya Research Topics

Disease

26	Hypercholesterolemia 06/2012 - 06/2002
12	Coronary Disease (Coronary Heart Disease) 09/2011 - 05/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 06/2012 - 09/2006
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 03/2007
8	Hypertension (High Blood Pressure) 03/2012 - 11/2005
5	Stroke (Strokes) 09/2009 - 11/2005
4	Obesity 03/2010 - 06/2006
3	Hyperlipidemias (Hyperlipidemia) 01/2017 - 01/2002
3	Cerebral Infarction 02/2009 - 09/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012 - 01/2005
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2012 - 09/2005
2	Atherosclerosis 01/2012 - 05/2002
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2011 - 03/2007
2	Unstable Angina 01/2011 - 03/2007
2	Myocardial Infarction 01/2011 - 03/2007
2	Diabetes Mellitus 10/2009 - 10/2008
2	Type 2 Diabetes Mellitus (MODY) 04/2007 - 02/2007
2	Hypertriglyceridemia 09/2003 - 05/2002
1	Heart Diseases (Heart Disease) 03/2012
1	Peripheral Arterial Disease 07/2010
1	Dyslipidemias (Dyslipidemia) 02/2009
1	Abdominal Obesity 08/2006
1	Cerebral Hemorrhage 09/2005

Drug/Important Bio-Agent (IBA)

21	LipidsIBA 03/2012 - 12/2002
12	Pravastatin (Pravachol)FDA LinkGeneric 06/2012 - 06/2002
10	CholesterolIBA 06/2012 - 12/2002
10	HDL CholesterolIBA 03/2012 - 09/2003
9	LDL CholesterolIBA 01/2017 - 09/2005
9	Simvastatin (Zocor)FDA LinkGeneric 03/2010 - 12/2002
8	Triglycerides (Triacylglycerol)IBA 01/2017 - 05/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 01/2008
6	oxidized low density lipoproteinIBA 03/2012 - 04/2007
6	Eicosapentaenoic AcidIBA 01/2012 - 07/2008
4	Glucose (Dextrose)FDA LinkGeneric 10/2009 - 08/2006
2	Fenofibrate (CiL)FDA LinkGeneric 01/2017 - 09/2003
2	Fluvastatin FDA Link 03/2012 - 01/2011
2	pitavastatin (itavastatin)FDA Link 06/2002 - 01/2002
1	Ezetimibe (Zetia)FDA Link 01/2017
1	A 19IBA 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Immunoglobulin M (IgM)IBA 10/2009
1	Lipoprotein(a)IBA 09/2009
1	Blood Glucose (Blood Sugar)IBA 04/2007
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 03/2007
1	LeptinIBA 06/2006
1	Transaminases (Aminotransferases)IBA 09/2003
1	ApolipoproteinsIBA 09/2003
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2003
1	Coenzyme A (CoA)IBA 01/2002
1	Oxidoreductases (Dehydrogenase)IBA 01/2002

Therapy/Procedure

9	Therapeutics 01/2017 - 12/2002
5	Secondary Prevention 03/2012 - 05/2002
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2011 - 03/2007